HarNeedi - Healthcare & Pharma Job Portal

Biopharma companies are crabbing up their drug research & development spending after staying stable all the way through last couple of years. According to industry sources,  research & development investments  will top $136 billion in 2013, up from $ 134 billion (2012); also the R&D expenditures estimated to exceed ($ 149 billion) by 2017. Drug Development Costs:  Average cost to develop a drug Early 2000s = $1.2 billion approx Late 1990s = $800 million Mid 1980s = $320 million 1970s = $140 million New medicine development – Big investors: According to recent industry surveys: NovoNordisk will have the fastest growth in Research & Development spending, from $1.8 billion in 2011 to $3.1 billion in 2018, an 8 % increase in investments. Novartis is predicted to spend on R&D the most $10.1 billion – by 2018. Roche is expected to spend $8.7 billion. Merck & Co., is expected to spend $7.6 billion. GlaxoSmithKline, is expected to spend $7...

Thanks to Medical research and Pharmaceutical companies, for their innovations, contributions to people's improved health and prolonged life. Now a days medicines can be found everywhere, as they cure, slow, prevent disease, aiding us to lead healthier and happier lives. How ever, A drug may be helpful or harmful, there are also many of harmful drugs that people consume to help them feel good. Many people are enticed by the excitement that drugs seem to offer. Administering drugs for medicinal purposes is nothing new, if we can see from the drug literature which is dispensed with the drug, there is a list of possible side effects from drugs to the consumer could feel. You may be panicked of the listed side effects and at the same time, you may be discouraged from taking the complete medicine course as required and directed by your doctor. However, there are medicines those may not produce a many side effects while there can be others that may produce very perceptible side effec...